The phrase "activated test" is correct and usable in written English.
It can be used in contexts related to testing procedures, particularly in technical or scientific fields where a test is initiated or made operational.
Example: "Before we proceed with the analysis, we need to ensure that the activated test is functioning properly."
Alternatives: "initiated test" or "enabled test".
Three ROTEM® tests were performed: extrinsically activated assay with tissue factor (EXTEM), intrinsically activated test using kaolin (INTEM), and extrinsically activated test with tissue factor and the platelet inhibitor cytochalasin D (FIBTEM).
A related study [ 65] of ROTEM® at emergency department (ED) admission demonstrated significantly lower values of platelet component of clot elasticity (MCE EXTEM, ROTEM® extrinsically activated test with TF and MCE FIBTEM, ROTEM® fibrin-based extrinsically activated test with TF and the platelet inhibitor cytochalasin D) in trauma nonsurvivors vs. survivors (P = 0.0012).
ROTEM® parameters significantly associated with MT include increased CFT [ 22, 31], decreased MCF [ 22, 31], prolonged EXTEM and INTEM CT (intrinsically activated test using ellagic acid, clotting time) [ 31] and FIBTEM A10 (ROC AUC, 0.83; 95% CI, 0.78 to 0.87) [ 31].
We activated and imaged 14 PSA tests, activating 1 at each concentration for free and total PSA and imaging the activated test up to 10 times each, under the same illumination conditions with the test held vertically in front of the Glass (see Figure 1 b).
Equal numbers of parental BC/BY cells or activated test cells BCS/BYA were mixed in culture medium deprived of IL-3 and seeded in 96-well black clear bottom microplates coated with Poly-D-Lysine (Becton Dickinson Biosciences, San Jose, California, USA) at a density of 20,000 cells per well using Titan Multidrop 384 automatic dispenser (Titertek Instruments, Inc., Huntsville, AL).
ROTEM® analyses (extrinsically-activated test with tissue factor (EXTEM), intrinsically-activated test using ellagic acid (INTEM) and fibrin-based extrinsically activated test with tissue factor and the platelet inhibitor cytochalasin D (FIBTEM) tests) were performed.
For the quantitative RDTs, we measured activated tests at various concentrations ranging from 0 to 200 ng/mL for free and total PSA.
However, during the time course of critical illness we noted decreases in CT and CFT and an increase in MCF in the tissue factor activated tests (EXTEM) compared with admission values (Table 3).
To activate testing for the current dictionary tick off 'Enable testing for this dictionary'.
Membrane pre-incubation with 100 n m MeSADP induced a right-shift of the CHA dose/response curve (EC50 = 106.26 ± 16.39 n m), suggesting a significant impairment in A1R-G protein coupling when P2Y1 receptor is activated (t-test, two-tails, unpaired P = 0.004 for EC50 of MeSADP-treated HC vs. control HC; Fig. 9).
We performed extrinsically activated thromboelastometric test (EXTEM), a test that uses rabbit brain thromboplastin as an activator, and fibrin-based thromboelastometric test (FibTEM), a test that assesses the fibrin-based clot using both extrinsic activation and addition of cytochalasin D to inhibit platelets' contribution to the formation of the clot.
